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Abstract
Human and animal pathogens are able to circumvent, at least temporarily, the sophisticated 
immune defences of their hosts. Several serovars of the Gram-negative bacterium Salmo-
nella enterica have been used as models for the study of pathogen–host interactions. In this 
review we discuss the strategies used by Salmonella to evade or manipulate three levels of 
host immune defences: physical barriers, innate immunity and adaptive immunity. During 
its passage through the digestive system, Salmonella has to face the acidic pH of the stomach, 
bile and antimicrobial peptides in the intestine, as well as the competition with resident 
microbiota. After host cell invasion, Salmonella manipulates inflammatory pathways and the 
autophagy process. Finally, Salmonella evades the adaptive immune system by interacting 
with dendritic cells, and T and B lymphocytes. Mechanisms allowing the establishment of 
persistent infections are also discussed.
Introduction
Salmonella spp. are pathogenic Gram-negative, rod-shaped, motile bacteria belonging to the 
family Enterobacteriaceae. The genus Salmonella includes the species S. bongori and S. enter-
ica. S. enterica is further divided into several subspecies and more than 2500 serovars (Tindall 
et al., 2005). Salmonella can cause gastroenteritis, typhoid fever, abortion, and bacteraemia, 
depending on the serovar and the host. For instance, S. enterica subspecies enterica serovar 
Typhi (S. Typhi) is responsible for typhoid fever in humans, whereas S. enterica subspe-
cies enterica serovar Typhimurium (S. Typhimurium) causes gastrointestinal inflammation 
in humans and a systemic typhoid-like disease in mice (Garai et al., 2012). Salmonella is a 
facultative intracellular pathogen that usually resides in a modified phagolysosome known 
as Salmonella-containing vacuole (SCV) during host infection. However, recent data indi-
cate that this facultative intracellular pathogen has a distinct bimodal lifestyle in epithelial 
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cells, where, there are subpopulations of vacuolar and cytosolic Salmonella (Knodler et al., 
2010). Target cells include M cells, gut epithelial cells, dendritic cells (DCs), macrophages, 
monocytes, neutrophils, B cells, and T cells. During its passage through the host, Salmonella 
must resist or evade multiple levels of immune defence. Many virulence genes contribute 
to the survival of these bacteria inside the host. Some of them are clustered in horizontally 
acquired genomic regions known as Salmonella pathogenicity islands (SPIs) (Gerlach and 
Hensel, 2007). The largest and best known are SPI1, which is present in all the members of 
the genus, and SPI2, which is present in S. enterica but not in S. bongori. These SPIs encode 
two distinct type III secretion systems, type III secretion system 1 (T3SS1) and type III 
secretion system 2 (T3SS2), respectively (Galán and Curtiss, 1989; Ochman et al., 1996; 
Shea et al., 1996). These systems are able to inject directly into the eukaryotic host cells 
a number of bacterial proteins known as effectors (Ramos-Morales, 2012a). Collectively, 
these virulence factors contribute to invade host cells, interfere with host cellular functions, 
subvert immunity, establish an intracellular niche, and promote pathogen proliferation.
In this review we summarize the mechanisms of immunity that pathogens in general 
have to face and the specific strategies that S. enterica uses to deal with the different levels of 
defence of the host.
Overview of mechanisms of immune defence
Humans, like any other animal are confronted every day to a myriad of microorganisms. 
However, these potentially infectious agents do not cause disease regularly due to a series of 
defence mechanisms that have been shaped over millions of years of evolution.
Three levels of immune defence can be recognized (Delves et al., 2011; Kenneth, 2011): 
(i) physical barriers, (ii) the innate immune system and (iii) the adaptive immune system.
Physical barriers
The best way to avoid infections is by keeping potentially infectious agents out of the body. 
Physical barriers are very effective for this purpose. They are represented by the skin and 
other epithelia covering the gastrointestinal, respiratory and urogenital tracts. These sur-
faces provide, not only mechanical, but also chemical and microbiological barriers.
The primary mechanical protection common to all epithelia consists of epithelial cells 
linked by tight junctions. The internal epithelia, or mucosal epithelia, are covered with 
mucous secretions. Mucus blocks the adherence of bacteria to epithelial cells. Microorgan-
isms trapped within it can be removed by the movement of cilia, coughing or sneezing. In 
the intestinal mucosa, mucus is secreted by specialized goblet cells and creates a physical 
barrier against microbial pathogens (Liévin-Le Moal and Servin, 2006). Other general 
mechanical factors that contribute to this first level of defence are the flow of air or other 
fluids, like the tears in the eyes.
In addition to these physical obstacles, a chemical barrier to infections is provided by sub-
stances that kill microbes or that inhibit their growth. These chemical substances include a 
group of antibacterial enzymes present in body fluids, like lactoperoxidase in milk, lysozyme 
and secretory phospholipase A2 in tears, nasal secretions and saliva. Lysozyme breaks the 
peptidoglycan (PG) in the bacterial cell wall of Gram-positive and Gram-negative bacteria. 
Phospholipase A2 kills bacteria by hydrolysing phospholipids in the cell membrane. Anti-
microbial peptides, like defensins, cathelicidins and histatins, represent another important 
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group of antimicrobial agents associated to epithelia. All of them are amphipathic peptides 
activated by proteolysis. Defensins and cathelicidins disrupt membranes and are toxic to 
many microorganisms, whereas histatins act against pathogenic fungi. Additional chemical 
barriers that are found by potential food pathogens include the acidity of the stomach pH 
and the bile in the intestine.
Microbiota is the microbial community composed of bacteria, protozoa, archaea, viruses 
and fungi that reside in different body niches. This microbiota competes with pathogenic 
microorganisms for nutrients and attachment sites. Therefore, the normal microbiota that 
is present in the intestine provides a microbiological physical defence against potential 
microbial pathogens that, like Salmonella, usually invade through the gut. In addition, some 
microbiota-produced metabolites affect the growth and virulence of pathogens. These 
metabolites include short-chain fatty acids, succinate, mucin O-glycans, molecular hydro-
gen, secondary bile acids, and the quorum sensing autoinducer AI-2 (Vogt et al., 2015).
Innate immune defence
The second level of defence is the innate immune response. This response occurs immedi-
ately after entry of a foreign agent into the body, but its effectiveness does not improve upon 
secondary encounter with the same agent. Microorganisms are recognized and killed by two 
main classes of phagocytic cells: polymorphonuclear neutrophils and macrophages. These 
cells carry pattern recognition receptors (PRRs) on their cytoplasmic membranes that 
adhere to pathogen-associated molecular patterns (PAMPs) on the microbe surface. PRRs 
include Toll-like receptors (TLRs), C-type lectin receptors (CTLRs), NOD-like receptors 
(NLRs), RIG-like receptors (RLRs) and scavenger receptors. PAMPs that activate TLRs 
include lipopolysaccharide (LPS), PG, lipoproteins, flagellin and other pathogen-derived 
ligands. Binding of a TLR to its ligand leads to activation of nuclear factor κB (NF-κB) and 
several members of the interferon-regulated factor (IRF) family of transcription factors. 
CTLRs are very diverse transmembrane proteins. RLRs are found in the cytoplasm and 
activate NF-κB and IRF3/4 to induce antiviral type I interferons in response to double-
stranded RNA. Scavenger receptors recognize modified low-density proteins, LPS and 
other ligands, and some of them can cooperate with TLRs (Murshid et al., 2016). NLRs 
are soluble cytosolic proteins that usually are composed of three domains: an N-terminal 
domain that recruits proteases or kinases, a central oligomerization domain and C-terminal 
leucine-rich repeats (LRRs) that recognize PAMPs. NLRs exist in an autoinhibited confor-
mation that is released upon binding to a PAMP, allowing oligomerization and recruitment 
of different host ligands depending on the particular NLR (Kim et al., 2016). The NLRs 
NOD1 and NOD2 induce autophagy to remove pathogens by recruiting ATG16L1 to 
the plasma membrane at the site of bacterial entry. Autophagy is a conserved intracellular 
degradation pathway that involves the formation of double-membrane vesicles, known as 
autophagosomes, which deliver cytosolic components to the lysosome for degradation. 
Microbe-induced autophagy, or xenophagy, is important to restrict the growth of a number 
of intracellular pathogens, including S. Typhimurium (Gomes and Dikic, 2014). NOD1 and 
NOD2 activate NF-κB and mitogen-activated protein kinase (MAPK) signalling pathways, 
whereas NLRP2 and NLRP4 are negative regulators of the NF-κB pathway. Some NLRs, as 
well as absent in melanoma 2-like receptors (ALRs) and pyrin, act as inflammasome sensors 
(Sharma and Kanneganti, 2016). The inflammasome is mainly activated in myeloid cells as 
an essential component of innate immunity that promotes caspase-1-induced conversion of 
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procytokines into active IL-1β and IL-18. It can result in an inflammatory form of cell death 
known as pyroptosis. Inflammasomes are cytosolic protein complexes that usually contain 
a specific sensor, an adaptor molecule (ASC) and pro-caspase-1. Canonical inflammasomes 
contain NLRP1, NLRP3, NLRC4, AIM2 or pyrin as sensors. NLRP3 is also involved in a 
non-canonical inflammasome that activates pro-caspase-11 in response to Gram-negative 
bacteria. This inflammasome is primed by recognition of LPS through a TLR and type I 
interferon signalling (Rathinam and Fitzgerald, 2016).
The general consequences of binding to PRRs include the activation of macrophages 
and neutrophils to increase their phagocytic activity, and the release of cytokines and 
chemokines that amplify the immune response. Once inside the phagocytic cell, the 
microorganism can be killed by reactive oxygen or nitrogen intermediates, by preformed 
antimicrobials like the defensins mentioned above or a neutral protease. This takes place 
with the assistance of other factors like low pH, lysozyme and lactoferrin. Other important 
cells in the innate immune system are natural killer cells, which identify host cells expressing 
abnormal patterns of proteins and induce apoptosis of these cells.
In addition to the cellular components of innate immunity, the complement system and 
other soluble circulating defensive proteins integrate the humoral innate immunity. The 
complement system is a multicomponent enzyme cascade that facilitates phagocytosis and 
lysis of microorganisms. This system can be activated by the lectin, classical or alternative 
pathways. All of the aforementioned generate a C3 convertase that leaves C3b bound to 
the microbial surface and releases C3a. C3b acts as an opsonin that increases the ability of 
phagocytes to ingest bacteria. C3a, together with C5a, recruit phagocytic cells to the site of 
infection and promote inflammation. Complement activation also leads to the formation 
of a membrane-attack complex that causes cell lysis. In addition, complement activation 
together with products of activated mast cells promotes inflammation, a response that leads 
to local swelling, redness, pain and temperature elevation.
Adaptive immune response
Unlike innate responses, acquired or adaptive immunity is able to recognize specific antigens 
and develop a response against these pathogens. In contrast to innate immunity, adaptive 
immunity is different in each individual of a species and responds to specific antigenic 
challenges, displaying then a flexible spectrum of action, as it is able to recognize millions 
of different antigenic molecules. The two major varieties of lymphocytes, B-lymphocytes 
and T-lymphocytes, are essential to generate humoral and cellular immunity, respectively. 
B-lymphocytes are able to make antibodies, specific antigen-recognition molecules, known 
as immunoglobulins, which deal with extracellular infections. T-lymphocytes are involved 
in the control of intracellular infections. Their receptors recognize processed antigens in 
association with molecules of the major histocompatibility complex (MHC). T cells are 
classified in two categories: CD4 (helpers) and CD8 (cytotoxic) T cells, which are acti-
vated upon recognition of an antigen presented by major histocompatibility complex class 
II (MHC-II) and major histocompatibility complex class I (MHC-I), respectively by the 
TCR. While MHC-I is present on most cell surfaces, MHC-II is expressed on antigen pre-
senting cells (APC).
A connection between the innate and adaptive immune systems at the level of cellular 
immunity is provided by DCs, which are relevant APCs. Stimulation of DCs by PAMPs 
triggers their maturation. Mature DCs present antigens to T cells via MHC molecules and 
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also provide co-stimulatory signals via B7 family ligands, promoting the activation of naive 
T cells. The interconnection between innate and adaptive immunity is also important for 
humoral immunity since the classical pathway to activate the complement requires immu-
noglobulin M (IgM) or immunoglobulin G (IgG).
Dealing with physical barriers
Acidic pH
Bacteria belonging to the genus Salmonella usually invade their hosts through oral inges-
tion of contaminated food or water. Lysozyme found in saliva is not a significant barrier for 
these pathogens since, like many other Gram-negative bacteria, they are capable of resisting 
it thanks to their outer membrane shield around the PG layer (Van Kesteren et al., 1942; 
Masschalck and Michiels, 2003). Therefore, the first real challenge that these bacteria have 
to face upon ingestion is the acidic pH of the stomach of the host (Ramos-Morales, 2012b) 
due to gastric secretions and hydrochloric acid. The pH value of the stomach is variable: a 
pH of 1.3 was observed in healthy humans in the fasted state and of 4.9 after meal ingestion 
(Russell et al., 1993). Values of 3.9 and 4.0 were measured in rats and mice, respectively, in 
the fasted state (McConnell et al., 2008). This low gastric pH can quickly kill enteric bac-
teria, but different bacterial species have developed mechanisms to survive during passage 
through the stomach. When compared with E. coli, that resists extreme acid stress and can 
survive at pH 2 for hours, S. enterica is much less acid resistant (Koutsoumanis and Sofos, 
2004; Lin et al., 1995). However, S. Typhimurium possesses at least three mechanisms 
of acid tolerance response (ATR) (Audia et al., 2001): (i) the exponential phase ATR is 
induced at pH 4.5–5.8 and allows subsequent survival at pH 3; (ii) the RpoS dependent 
stationary phase ATR is pH independent and is part of a general stress response; (iii) the 
RpoS independent stationary phase ATR is induced by exposure to pH 4.5 and provides 
longer tolerance to pH 3 than the RpoS dependent system. These tolerance systems require 
acid shock proteins whose synthesis is regulated by RpoS, the iron regulatory protein Fur 
or the two-component systems PhoQ/PhoP or EnvZ/OmpR (Audia et al., 2001; Foster, 
1993). Small RNAs (sRNAs) have recently been identified as major regulators of stress 
response networks. For instance, the sRNA DsrA influences the ATR and virulence in 
S. Typhimurium (Ryan et al., 2016).
Bacteria that are able to survive the passage through the stomach must face new chal-
lenges in the intestine before establishing an intracellular niche. This includes mucus, bile, 
antimicrobial peptides and the resident microbiota (Fig. 6.1).
Mucus
Epithelial cells in the human gut are covered with mucous secretions that protect the epi-
thelium from the environment. The mucus barrier is composed of at least two glycan layers, 
which in turn incorporate multiple layers of glycoproteins (mucin) and complex oligosac-
charides (glycocalyx) that protect cells from the local environment and infection. Microbes 
are able to use the host glycan as nutrients that regulate bacterial infection and virulence 
(Marcobal et al., 2013). Intestinal intracellular pathogens have to penetrate the mucin layers 
and subsequently gain access to the cell membrane. In order to achieve this, Salmonella uses 
a set of glycosyl hydrolases (GHs) that are able to degrade glycans. Recently, Arabyan et al. 
(2016) investigated the specific enzymes used by Salmonella to degrade the glycan. They 
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identified two specific glycan-degrading enzymes in Salmonella, NanH and MalS, as new 
virulence factors. These enzymes are expressed during in vitro infection of human colonic 
epithelial cells (Caco-2) and degrade the glycocalyx layer produced by these cells. The 
authors also analysed the host response to glycan degradation and they observed induced 
expression of host genes that hydrolyse mannose, fucose, and N-acetylneuraminic acid 
(Neu5Ac) from the glycan; as well as sialyltransferases, suggesting host glycan remodelling 
during infection (Arabyan et al., 2016).
Bile
Bile is a secretory and excretory fluid produced in the liver whose composition varies 
depending on the individual’s diet (Coleman, 1987). Secretory functions include: delivery 
to the intestinal tract of bile salts to aid fat digestion and absorption/secretion of polymeric 
IgA to prevent infection in the biliary and upper intestinal tracts. In addition, bile is the 
excretory vehicle of liver-derived metabolites of potentially toxic materials. Bile contains 
inorganic ions, bile salts, lipids (phosphatidylcholine, cholesterol) and proteins (plasma 
proteins, liver-specific proteins, polymeric IgA). It is a bactericidal agent that disrupts 
Figure 6.1 Schematic representation of Salmonella strategies to circumvent host physical 
barriers. After ingestion of contaminated food or water, Salmonella crosses the stomach where 
it is able to resist to acidic pH activating an acid tolerance response. Then Salmonella reaches 
the intestine where it has to face different chemical challenges, like the bile produced in the liver 
or antimicrobial peptides secreted by Paneth cells in the gut. In addition to that, Salmonella 
has to compete with the resident intestinal microbiota for essential nutrients. Interestingly, 
Salmonella triggers an inflammation response in the gut that offers different nutrients or 
adhesion receptor sites that can be exploited only by pathogens.
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bacterial cell membranes due to the detergent activity of bile acids (Begley et al., 2005), 
causes DNA damage (Prieto et al., 2004, 2006) and alters the conformation of proteins. 
Salmonella, however, resists bile through different mechanisms. First, the bacterial cell enve-
lope acts as a barrier to membrane-active agents like bile salts. Two components of the outer 
membrane are important for bile resistance: the LPS (Crawford et al., 2012; Gunn, 2000) 
and the enterobacterial common antigen (ECA) (Ramos-Morales et al., 2003). Recently, it 
has been shown that exposure to the bile salt sodium deoxycholate is associated with changes 
in the structure of the second layer of the cell envelope, the PG, and that PG remodelling 
contributes to bile resistance (Hernández et al., 2015). Once bile enters the cell, additional 
mechanisms are activated. Efflux pumps mediate the export of bile salts from the bacterial 
cytoplasm to the outside medium and are responsible for resistance to many different toxic 
compounds (Nishino et al., 2006). AcrAB-TolC is the best characterized efflux system in 
enteric bacteria (Ma et al., 1993, 1995; Nikaido et al., 2008; Zgurskaya and Nikaido, 1999). 
AcrB is an inner-membrane protein, TolC is the outer membrane component and AcrA is 
located in the periplasm. The genes encoding these proteins are regulated by the transcrip-
tional regulator RamA, which is synthesized in response to bile (Baucheron et al., 2014). In 
addition, bile-induced DNA damages can be repaired by Dam-directed mismatch repair and 
by base excision repair, and the impairment of DNA replication rescued by SOS-dependent 
translation DNA replication and RecBCD-dependent recombinational repair (Prieto et al., 
2006). Finally, Salmonella is also able to adapt to grow in extremely high bile concentra-
tions if previously exposed to sublethal doses. This is a transitory state that involves multiple 
changes in gene expression (Prouty et al., 2004). The RpoS-dependent general stress 
response plays a crucial role in the adaptation of Salmonella to bile (Hernández et al., 2012).
Antimicrobial peptides
Different families of antimicrobial peptides protect the intestine. Defensins and catheli-
cidins are of special interest in the context of gastrointestinal infections (Wehkamp et al., 
2007). They are produced in the intestinal epithelium either constitutively or in an induc-
ible manner. For instance, Paneth cells of the small intestine express the most abundant, 
constitutively expressed defensins. Human cathelicidin is expressed by epithelial cells in the 
stomach, small bowel and colon. In this context, butyrate, a short-chain fatty acid produced 
in the colon by bacterial fermentation of dietary fibres, has been shown to induce expres-
sion of the human cathelicidin gene. Salmonella is able to sense sublethal concentrations of 
antimicrobial peptides and induce several mechanisms of resistance that involve modifica-
tion of the LPS or sequestering, efflux and proteolytic degradation of antimicrobial peptides 
(Matamouros and Miller, 2015). Regulatory proteins involved in this process include the 
alternative sigma factor RpoE and the two-component or phosphorelay systems PhoQ/
PhoP, PmrA/PmrB and Rcs. PhoQ is an inner-membrane histidine kinase that senses 
antimicrobial peptides (Bader et al., 2003, 2005) and phosphorylates the response regula-
tor PhoP. Activation of PhoP prevents dephosphorylation of PmrA (Kato and Groisman, 
2004). This protein directly controls expression of genes involved in LPS modifications 
necessary for resistance to antimicrobial peptides. The Rcs system is a phosphotransfer cas-
cade that responds to antimicrobial peptides through RcsF (Farris et al., 2010). This system 
controls the synthesis of colanic acid capsule and the transcription of other genes necessary 
for resistance (Detweiler et al., 2003). Modifications of the bacterial surface that contribute 
to antimicrobial peptide resistance include: 
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1 Regulation of O-antigen length by the PmrA/PmrB system (Farizano et al., 2012; 
Pescaretti et al., 2011).
2 Modification of the anionic phosphate groups in the core and lipid A regions of the 
LPS by addition of aminoarabinose and phosphoethanolamine. PmrA is involved in 
the regulation of these modifications as well as in the inhibition of the activity of LpxT, 
which is responsible for increasing the negative charge of LPS by adding an additional 
phosphate. Together these changes lead to a reduction of the negative charge of the 
outer membrane and of the electrostatic interactions with antimicrobial peptides 
(Gunn et al., 1998; Herrera et al., 2010; Jones et al., 2008a; Lee et al., 2004; Zhou et al., 
2001b).
3 Decrease in the fluidity of the outer membrane by the incorporation, catalysed by PagP, 
of an additional palmitate to lipid A and to phosphatidylglycerol (Bishop et al., 2000; 
Dalebroux et al., 2014; Guo et al., 1998). 
Additional resistance mechanisms involve binding, efflux or degradation of antimicro-
bial peptides. The two PhoP-regulated proteins Mig-14 and VirK are suggested to bind 
antimicrobial peptides to prevent their penetration into Salmonella (Brodsky et al., 2005). 
The sapABCDF operon encodes an ABC transporter system involved in resistance to anti-
microbial peptides (Parra-Lopez et al., 1993). It has been proposed that the SapABCDF 
transporter system functions as a complex with SapG and SapJ to mediate both peptide and 
K+ transport (Parra-Lopez et al., 1994). Finally, PgtE is a post-transcriptionally regulated 
component of the PhoQ/PhoP regulon with protease activity against alpha-helical cationic 
antimicrobial peptides (Guina et al., 2000).
Intestinal microbiota
Before invading appropriate host cells and becoming an intracellular pathogen, Salmonella 
has to compete with the resident intestinal microbiota. The lumen of the human gastroin-
testinal tract is rich in nutrients and provides an appropriate niche for a diverse community 
of bacteria (Bäckhed et al., 2005). They increase in number from the stomach to the colon, 
where they reach concentrations around 1012 per gram of luminal content. Most colonic 
bacteria are members of the Firmicutes and Bacteroidetes phyla, whereas Proteobacteria, 
Actinobacteria, Fusobacteria and Verrucomicrobia are less abundant (Eckburg et al., 2005). 
This microbiota helps to prevent infection by providing a physical barrier for the attach-
ment of bacterial pathogens to the mucosal surfaces and competing with pathogens for 
essential nutrients (van der Waaij et al., 1971). Salmonella, however, can exploit the host 
innate immune response and its own metabolic capacities to overcome, at least temporarily, 
this barrier (Khan, 2014). First, the initial growth of Salmonella in the gut is powered by 
Hyb hydrogenases that enable the bacteria to use hydrogen produced by the resident micro-
biota as a central intermediate of metabolism (Maier et al., 2013). Using a mouse colitis 
model, it has been shown that inflammatory host responses triggered by S. Typhimurium 
virulence factors (T3SS effectors) shift the competition in favour of the pathogen (Stecher 
et al., 2007). The mechanisms leading to this result are not completely understood and dif-
ferent explanations have been proposed: (i) inflammation involves release of antibacterial 
factors that may kill or delay the growth of specific members of the microbiota that would 
normally inhibit Salmonella growth; and (ii) the inflamed intestine could offer different 
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nutrients or adhesion receptor sites that can be exploited only by pathogens. In particular, 
reactive oxygen species generated by neutrophils during inflammation can react with endog-
enous thiosulfate to form tetrathionate. The ttrRSBCA locus, located in SPI2, confers to S. 
Typhimurium the ability to use tetrathionate as a terminal electron acceptor in anaerobic 
respiration (Winter et al., 2010a). This confers a growth advantage because, unlike most 
bacteria in the gut, S. Typhimurium can use ethanolamine as a carbon source in the presence 
of tetrathionate as a respiratory electron acceptor (Thiennimitr et al., 2011). It has also been 
suggested that the ability of S. Typhimurium to degrade fucose and anaerobically degrade 
1,2-propanediol, probably using tetrathionate as a terminal electron acceptor, provides 
an advantage to this pathogen during competition with the microbiota (Staib and Fuchs, 
2015). In addition, some S. Typhimurium isolates carry the gene sopE in a prophage. The 
product of this gene increases the severity of intestinal inflammation and drives the host to 
generate an additional terminal electron acceptor, nitrate, that suppresses genes responsible 
for utilization of energetically inferior electron acceptors such as tetrathionate (Lopez et al., 
2012). Stecher et al. (2012) described in an interesting study the discovery of a mechanism 
driving efficient conjugation between Enterobacteriaceae (S. Typhimurium and E. coli) in 
the host’s intestine. Using a mouse colitis model, the authors observed parallel blooms of 
pathogenic S. Typhimurium and resident commensal E. coli. This phenomenon, probably 
due to dysbiosis of the anaerobic microbiota caused by Salmonella infection, led E. coli to 
account for > 80% of the total intestinal bacteria. In this scenario, the authors observed con-
jugative horizontal gene transfer efficiencies of 100%. This suggests that bacterial blooms 
occur after Salmonella infection fuels the reassortment of genetic material between different 
Enterobacteriaceae. This further implies that infected patients might enhance the spread of 
plasmid-encoded fitness, virulence- and antibiotic resistance determinants (Stecher et al., 
2012).
Evasion of the innate immune system
Salmonellae that are able to deal with the aforementioned physical barriers can invade the 
gut epithelium, preferentially in the distal ileum, using several routes. They usually invade 
microfold cells (M cells) that overlie Peyer’s patches, but they can also induce their own 
uptake by epithelial cells or be engulfed by CD18+ phagocytes, probably monocytes or den-
dritic cells (Watson and Holden, 2010). In a systemic infection, Salmonella can disseminate 
to internal organs [mesenteric lymph nodes (MLNs), liver and spleen]. Access to other cell 
types, like macrophages, could be a consequence of cell death induction (Fink and Cookson, 
2007) and subsequent phagocytosis. Both intracellularly and during the transient extracel-
lular passage from one host cell to another, Salmonella has to face and resist components of 
the innate immune system.
Salmonella finds cationic antimicrobial peptides not only in the intestinal lumen but also 
inside macrophages. Resistance mechanisms against this innate defence were described 
in the previous section. Interestingly, the PhoQ/PhoP two component system, that sense 
these antimicrobial peptides, are also additively activated by intracellular signals (acidic pH 
and divalent cation limitation). However the presence of antimicrobial peptides could be 
the most relevant signal for systemic virulence (Hicks et al., 2015).
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Manipulation of inflammatory pathways
Relevant PRRs for the recognition of Salmonella PAMPs are members of the TLR family, 
associated to host membranes, and members of the NLR family, that recognize the presence 
of PAMPs in the cytosol. This recognition leads to the activation of the NF-κB pathway 
(O’Dea and Hoffmann, 2010). Specific Salmonella virulence factors that enhance NF-κB 
activity are the T3SS1 effector SopE, which is recognized by NOD1 (Keestra et al., 2013), 
and the T3SS2 effector SrfA, that promotes NF-κB activation by binding to TOLLIP, an 
inhibitor of IRAK1 (Lei et al., 2016). This proinflammatory pathway can also be induced 
by the T3SS needle proteins PrgI and SsaG through TLR2 and TLR4 ( Jessen et al., 2014). 
In addition, SopE acts as a GTP exchange factor (GEF) for Rho family GTPases Cdc42 
and Rac1, leading to activation of the c-Jun N-terminal kinase ( JNK) pathway. Three dif-
ferent Salmonella proteins have been involved in inflammasome activation: (i) flagellin, an 
inducer of the NLRC4 inflammasome injected through T3SS1; (ii) Prg J, a component of 
the basal body inner rod of T3SS1, also detected by NLRC4 (Miao et al., 2010a); (iii) SopE 
contributes to inflammasome activation through its GEF activity, although the specific 
inflammasome sensor has not been determined (Hoffmann et al., 2010; Müller et al., 2009). 
NLRP3 has been suggested to have also an important role in innate immune defence against 
S. Typhimurium, since mice lacking both NLRP3 and NLRC4 are significantly more sus-
ceptible to infection (Broz et al., 2010). It has been recently shown that NLRP3 associates 
with NLRC4 in macrophages infected with S. Typhimurium or transfected with flagellin, 
revealing an unexpected overlap between two distinct inflammasomes (Qu et al., 2016). 
S. Typhimurium and other Gram-negative bacterial pathogens could induce a non-canonical 
inflammasome involving cytosolic recognition of LPS and activation of caspase-11 in mice 
and caspase-4 in humans (Broz and Monack, 2013a; Broz et al., 2012; Casson et al., 2015; 
Storek and Monack, 2015). This activation has been observed in the context of infections 
with mutants that aberrantly enter the cytosol (Aachoui et al., 2013) after lysis of the SCV 
dependent on IFN-induced GTPases (Meunier et al., 2014). However, wild-type S. Typh-
imurium can also lyse their nascent vacuole following invasion of tissue culture epithelial 
cells and enter the cytosol where it can eventually hyper-replicate (Birmingham et al., 2006; 
Knodler et al., 2014). Using a semi-quantitative single-cell analysis, Malik-Kale et al.,showed 
that although cytosolic hyper-replication occurs in less than 20% of infected epithelial 
cells, it accounts for the majority of net intracellular replication (Malik-Kale et al., 2012). 
Interestingly, the transcriptional profiling of both intracellular bacterial subpopulations are 
different and it is known that cytosolic Salmonella are induced for T3SS1 and flagellated, 
whereas vacuolar bacteria are T3SS2-induced (Knodler et al., 2010). Eventually, cytosolic 
hyper-replication leads to epithelial cell death via pyroptosis. This results in cell lysis, proin-
flammatory cytokine release and escape of the cytosolic bacteria into the extracellular space, 
providing a potential mechanism of dissemination (Knodler, 2015).
Anti-inflammatory response to Salmonella infection
Although an initial inflammatory response is beneficial for Salmonella to outcompete the 
microbiota, as the intracellular infection progresses, the pathogen still has mechanisms to 
inhibit inflammatory pathways (Fig. 6.2). Down-regulation of flagellin expression in sys-
temic sites is a way to prevent NLRC4 inflammasome activation (Cummings et al., 2006; 
Miao et al., 2010b; Winter et al., 2010b). Control of bacterial production of the tricarbox-
ylic acid (TCA) cycle metabolite citrate may contribute to evade NLRP3 inflammasome 
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activation in macrophages (Wynosky-Dolfi et al., 2014). In addition, many T3SS effectors 
have an anti-inflammatory role. Both the T3SS1 effector AvrA and the T3SS2 effector SseL 
deubiquitinate IκBα and inhibit its degradation (Le Negrate et al., 2008; Ye et al., 2007). 
Binding of IκBα to NF-κB prevents its translocation to the nucleus. AvrA also inhibits 
JNK-induced signalling (Du and Galán, 2009; Jones et al., 2008b; Wu et al., 2012). GogA, 
GtgA and PipA are members of the same family of proteases that redundantly cleave 
specific members of the NF-κB family, including RelA (p65) and RelB (Sun et al., 2016). 
SspH1 localizes to the mammalian nucleus and inhibits NF-κB-dependent gene expression 
through interaction with protein kinase 1 (PKN1) (Haraga et al., 2006). The effector SptP 
consists of two domains. The N-terminal domain acts as a GAP for Cdc42 and Rac1 that 
mediates reversion of the effects of SopE on the actin cytoskeleton (Fu and Galán, 1999). 
The C-terminal domain possesses tyrosine phosphatase activity, which is (Kaniga et al., 
1996) involved in reversing the initial activation of the MAPK ERK, triggered by Salmo-
nella infection (Murli et al., 2001). SptP inhibits this MAPK pathway through inhibition 
of Raf1 activation in a process that involves both SptP activities (Lin et al., 2003). This 
down-modulation of ERK activation could explain the contribution of SptP, together with 
SspH1, towards the inhibition of IL-8 production after invasion of intestinal epithelial cells 
(Haraga and Miller, 2003). Another effector involved in reduction of the production of 
inflammatory cytokines through the inactivation of ERK is SpvC. This effector is encoded 
in a virulence plasmid present in some S. enterica serovars and can be secreted by T3SS1 
and T3SS2. SpvC inactivates ERK by irreversibly removing phosphate from a threonine 
residue in the conserved activation loop motif TXY using its phophothreoninelyase activity 
Figure 6.2 Schematic illustration of mechanisms of Salmonella to manipulate the host 
immune system by injecting effector proteins through two T3SS. Salmonella triggers 
its own internalization into the host cell in a T3SS1-dependent manner. Following 
internalization, Salmonella establishes its intracellular niche in a modified phagosome, called 
Salmonella-containing vacuole (SCV), where the pathogen manages to survive and proliferate. 
Biogenesis and maturation of the SCV depends on the activity of T3SS 1 and 2 effectors that 
manipulate the normal endocytic pathway to avoid the fusion and degradation by a lysosome. 
The actions of the T3SS proteins effectors on the inflammatory pathways to evade the host 
immune system are schematically represented.
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(Mazurkiewicz et al., 2008). Interestingly, during the interaction of Salmonella with the 
plant model Arabidopsis, SpvC interacts with and dephosphorylates activated MAPK6 
to inhibit defence signalling (Neumann et al., 2014). This suggests that some Salmonella 
effector proteins could have a conserved function during proliferation in different hosts. 
GogB is another anti-inflammatory effector that limits NF-κB activation by targeting the 
host SCF E3 ubiquitin ligase and inhibiting IκBα degradation (Pilar et al., 2012). SseK1, an 
effector protein that can be secreted by T3SS1 and T3SS2 (Baisón-Olmo et al., 2015), has a 
N-acetylglucosamine transferase activity that modifies the TNF-α receptor TNFR1 and its 
adaptor TRADD, preventing TNF-α mediated activation of NF-κB (Li et al., 2013).
An important mediator of the anti-inflammatory effects of Salmonella is haem-oxygenase 
1 (HO-1). HO-1 is an anti-stress regulatory molecule. It catabolyses the degradation of 
haem into biliverdin with the production of free iron and CO. Different studies have shown 
that HO-1 can be induced by a wide variety of bacteria. This is likely due to the increase in 
oxidative stress and inflammation (reviewed in Blancou et al., 2011). Onyiah et al. (2013). 
using a colitis mouse model, showed that the enteric microbiota induces expression of 
HO-1 in mice and zebrafish. HO-1-derived CO enhances macrophage bactericidal activity 
and bacterial clearance in vivo. Similarly, others works have shown that an absence of HO-1 
in humans and mice leads to chronic inflammation (Chung et al., 2008; Yachie et al., 1999), 
although the exact mechanisms remains unclear. One hypothesis emerged from the experi-
ments performed by Choi and Lee, who showed a positive feedback of the system in which 
CO stimulates the synthesis of the anti-inflammatory cytokine interleukin 10 (IL-10) by 
macrophages (Otterbein et al., 2000). IL-10 induces the expression of HO-1 potentially 
leading to a self-amplification of the anti-inflammatory effect (Lee and Chau, 2002). Others 
propose that HO-1 controls early innate immune response of S. Typhimurium-infected 
macrophages. In this study, a reduced survival of intracellular Salmonella in cells with low 
HO-1 expression was observed, probably due to the limited iron availability and to the 
activation of pro-inflammatory pathways that occurs in the absence of this enzyme (Mit-
terstiller et al., 2016). On the other hand, Salmonella-infected macrophages with strongly 
up-regulated HO-1, provide a survival niche for Salmonella (Nix et al., 2007). Thus, the 
induction of HO-1 expression has been suggested to be a strategy of the pathogen, given its 
harmful effects in the early control of Salmonella infection.
Another example of the immunosuppressive role of HO-1 was described by Riquelme et 
al. (2015), who suggest HO-1 prevents T-cell-mediated inflammatory disease by producing 
CO and impairing DC immunogenicity. CO has been shown to impair the mitochondrial 
function in DCs by reducing both the mitochondrial membrane potential and ATP produc-
tion. This gas is able to impair the endo-lysosomal antigen trafficking route, reducing the 
ability of DCs to prime naive T cells. The role of HO-1 in immunity has been also studied 
in DCs, where CO is the molecule with the most prominent immunosuppressive capacity 
over their function (Rémy et al., 2009; Tardif et al., 2013). Contrary to this, other authors, 
like Zaki et al., suggest that HO-1 contributes to improved control of Salmonella replication 
within macrophages by exerting a cytoprotective effect (Zaki et al., 2009). Further studies 
are necessary to clarify the dual role of HO-1 in infections.
Autophagy
The relationship of Salmonella with autophagy is also of interest. During S. Typhimurium 
infection, T3SS1-mediated damage of the SCV allows ubiquitin and galectin-8 to target 
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bacteria inside the affected SCVs or free in the cytoplasm (Birmingham and Brumell, 2006; 
Birmingham et al., 2006; Thurston et al., 2012). These signals recruit essential anti-bacterial 
autophagy components including several cargo receptors, the kinase TBK1 and WIPI2, that 
restrict Salmonella proliferation (Radtke et al., 2007; Thurston et al., 2016, 2009, 2012). 
Autophagy has also a role in sealing damaged endosomal membranes, allowing T3SS2 
induction inside the SCV (Kreibich et al., 2015; Owen and Casanova, 2015). In epithe-
lial cells, Salmonella induces the formation of ubiquitinated aggregates near the SCV in a 
T3SS2-dependent manner. These aggregates are recognized by the autophagy machinery. 
The T3SS2 effector SseL is a deubiquitinase whose activity lowers autophagic flux and 
favours intracellular Salmonella replication (Mesquita et al., 2012). In a recent study that 
used a fibroblast-infected model, López-Montero et al. (2016) showed that S. Typhimurium 
develops membranous aggregates connected to the phagosome where the bacteria controls 
its progeny and establishes an intracellular persistent infection. In addition, T3SS2 mediates 
active suppression of autophagic signalling in macrophages through recruitment of focal 
adhesion kinase (FAK) to SCVs and activation of the Akt-mTORC1 signalling pathway 
(Owen et al., 2014). The inhibition of autophagy by Salmonella also prevents the induc-
tion of a protective cytokine response mediated by interferon beta (IFN-β) (Owen et al., 
2016). Two recent studies show that SpvB, a T3SS2 effector with ADP-ribosyltransferase 
activity that prevents polymerization of G-actin into F-actin filaments (Hochmann et al., 
2006; Lesnick et al., 2001; Margarit et al., 2006; Tezcan-Merdol et al., 2001), can inhibit 
autophagosome formation and increase inflammatory injury in zebrafish intestine (Li et al., 
2016) mammalian cells and mice (Chu et al., 2016). This inhibition occurs at the early stage 
of autophagy via depolymerization of actin filaments.
The complement system
Finally, mechanisms to evade or interfere with the complement system have evolved in 
Salmonella. The human pathogen S. Typhi expresses the Vi capsular polysaccharide during 
transit through the intestine (Tran et al., 2010). This polysaccharide has anti-inflammatory 
properties, (Sharma and Qadri, 2004) and also inhibits complement deposition (Looney 
and Steigbigel, 1986; Wilson et al., 2011). This, thanks to a lack of hydroxyl groups avail-
able for ester formation with C3b (Heyns and Kiessling, 1967). Evolution of these immune 
evasive properties of S. Typhi led to inactivation of the fepE gene, encoding a regulator of 
very-long O-antigen chains (Crawford et al., 2013). The surface protease PgtE of S. Typh-
imurium affects complement activity by cleaving C3b, C4b, C5, B and H complement 
components (Ramu et al., 2007; Riva et al., 2015). Although factors B and H have opposite 
effects on complement activation, the overall effect of PgtE favours protection of Salmonella 
against the host immune system, since less C3-derived fragments accumulated on Salmo-
nella and the association with neutrophils was reduced (Riva et al., 2015).
Mechanisms to escape adaptive immunity
In addition to mechanisms developed by Salmonella to escape from innate immunity, this 
intracellular pathogen has acquired different mechanisms to evade different adaptive immu-
nity mechanisms.
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Interactions of Salmonella enterica with dendritic cells
Innate and adaptive immunities are linked by DCs. Therefore, the activation of an effec-
tive adaptive immune response relies on efficient DCs capable of priming of naive T cells. 
This is one of the most relevant immune evasion strategies for Salmonella. This pathogen 
has developed molecular mechanisms to prevent the presentation of bacterial antigens that 
prime naive T cells and therefore avoid the initiation of the adaptive immunity.
In general, virulent strains of Salmonella are capable of modulating phagocytosis by DCs, 
avoiding lysosomal degradation and preventing antigen presentation to T cells. Here, we 
summarize the mechanisms developed by Salmonella to escape from acquired immunity. 
It is well known that Salmonella is able to induce phagocytosis on epithelial cells by active 
translocation of T3SS1 effectors which modulate the actin cytoskeleton. This results in 
internalization of Salmonella into the epithelial cell (Scherer et al., 2000; Steele-Mortimer 
et al., 2002; Zhou et al., 2001a). In contrast, the uptake of Salmonella by DCs is tightly regu-
lated by effector proteins of T3SS1 (Bueno et al., 2010), being able to control the amount 
of bacteria that enter into the cells, avoiding then a massive immune response that would 
restrict Salmonella replication and dissemination. Additionally, Riquelme et al. showed that 
IgG-opsonized Salmonella are recognized by different receptors (FcyRIII receptors and 
others that have not been identified) expressed on DCs surfaces. These immune complexes 
are internalized and degraded by the lysosomal route, restoring its capacity to present Sal-
monella antigens to T cells and initiate an adaptive immunity response. However, the exact 
molecular mechanism with which IgG interferes with the secretion of Salmonella virulent 
effectors or impair its capacity to evade capture in DCs remains unclear (Riquelme et al., 
2012).
After internalization, establishing a systemic infection depends on the pathogen’s capac-
ity to survive inside the host cells and to evade the immune response. In that sense, there 
are many studies on Salmonella virulence proteins that contribute to intracellular survival 
in DCs and dissemination in the host (Albaghdadi et al., 2009). One of the most relevant 
strategies developed by Salmonella to survive and replicate intracellularly is the disruption 
of the host endocytic trafficking machinery to avoid its lysosomal degradation within the 
SCV. The ability to survive in DCs is dependent on SPI2 effectors (Albaghdadi et al., 2009; 
Halici et al., 2008; Jantsch et al., 2003), which are injected to DCs cytosol from the SCV 
through a T3SS2. In fact, T3SS2 mutants show a reduced capacity to survive inside DCs and 
are attenuated in mice (Tobar et al., 2006). However, there are several examples of T3SS1 
effectors that participate in avoiding lysosomal fusion. Among these SPI1 effectors, SopB 
and SopE were found to play a role in SCV maturation (Hernandez et al., 2004; Mukherjee 
et al., 2001). SopB is a phosphatase that mediates phosphatidylinositol 3-phosphate produc-
tion in the SCV, through Rab5 recruitment to the SCV and its effector Vps34 (Mallo et al., 
2008). Another example is SopE, which acts as a Rab5-specific exchange factor and medi-
ates the recruitment of Rab5 in the GTP form in the SCV (Mukherjee et al., 2001). There 
are also examples of T3SS2 effectors that impair trafficking of endocytic cargo to lysosomes. 
The effector SopD2 directly binds and inhibits the host GTPase Rab7, a regulatory switch 
central to endocytic trafficking and phagosome–lysosome fusion. Consequently, this limits 
Rab7 interaction with its dynein- and kinesin-binding effectors RILP and FYCO1. This in 
turn disrupts the regulation of microtubule motors (D’Costa et al., 2015). SifA is another 
SPI2 effector required for bacterial survival inside DCs that alters lysosomal function 
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(Beuzón et al., 2000; Boucrot et al., 2003; Petrovska et al., 2004). McGourty et al. showed 
that SifA prevents the delivery of hydrolytic enzymes to the SCV by inhibiting Rab9-
dependent retrograde trafficking of mannose-6-phosphate receptors (MPRs). This requires 
binding of SifA to its host cell target SKIP. Translocated SifA forms a stable complex with 
SKIP and Rab9 in infected cells. Sequestration of Rab9 by SifA-SKIP accounts for the effect 
of SifA on MPR transport and lysosome function (McGourty et al., 2012). There are other 
effectors of the T3SS2 that are involved in DC intracellular survival of Salmonella like SseJ, 
SseF, SspH2 and PipB2. Strains lacking these effectors show reduced survival inside DCs 
but the specific role of each of these virulence proteins remains unclear (Halici et al., 2008).
One of the suggested strategies used by Salmonella to avoid antigen presentation is inhi-
bition of lysosomal degradation (Tobar et al., 2006, 2004). There are studies that suggest 
that the PhoQ/PhoP regulatory system is involved in this escape mechanism. This because 
Salmonella strains with mutations in the PhoQ/PhoP system are not able to escape from 
lysosomal degradation and therefore do not interfere with antigen processing and presenta-
tion (Niedergang et al., 2000). Other studies report that Salmonella regulates the expression 
of MHC class II antigens by polyubiquitination of HLA-DR. (Lapaque et al., 2009). These 
mechanisms rely on virulence factors encoded in SPI2. T3SS2 effectors like SifA, SlrP, 
SspH2, PipB2 and SopD have been shown to participate in this evasion process since they 
are required for the inhibition of MHC-II-dependent antigen presentation in DCs (Halici et 
al., 2008). The ability of Salmonella to prevent antigen presentation by DCs seems to depend 
exclusively on SPI2-related proteins, since a mutant strain lacking the T3SS1 is still able to 
avoid antigen presentation by DCs (Bueno et al., 2010). Importantly, this feature seems to 
be host specific and restricted to serovar Typhimurium, since other serovars like S. enteritidis 
and S. Typhi are not able to interfere with this function in murine DCs (Bueno et al., 2008).
S. Typhimurium can interfere with the host’s immune response during oral infection of 
mice through selective killing of CD8α+ DCs in a process that is dependent on MyD88 and 
TNFR1 (Sundquist and Wick, 2009). It has been recently shown that the pRST98 plasmid 
of S. Typhi may also influence maturation, survival and cytokine production of DCs, pre-
venting activation of T-cell-mediated immunity against antigens derived from this pathogen 
(Wei et al., 2015).
Another strategy used by virulent Salmonella is based on down-regulation of flagellin, 
a target of the innate and adaptive immune responses during infection. This strategy con-
sists in preventing T-cell activation by the active reduction of the availability of bacterial 
antigens for presentation to T cells (Alaniz et al., 2006). Some data suggest that flagellin is 
differentially expressed by Salmonella populations infecting Peyer’s patches (Cummings et 
al., 2006). Furthermore, intracellular Salmonella can make flagellin unavailable for antigen 
processing by DCs (Alaniz et al., 2006). Similar studies showed that during low-dose Salmo-
nella infections, the microbe evades activation of flagellin-specific CD4 T cells (Srinivasan 
et al., 2004).
Direct interactions of Salmonella enterica with T cells
Examples of S. Typhimurium directly blocking T-cell proliferation are prevalent in the 
literature. This inhibition was observed in both CD4+ and CD8+ T cells and was due to a 
down-regulation of TCR expression β-chain, which interferes with the first step in T-cell 
clonal expansion (van der Velden et al., 2005, 2008). The authors of the aforementioned 
study also identified the enzyme l-asparaginase II as responsible for this inhibitory effect. 
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The activity of this enzyme causes depletion of exogenous l-asparagine, leading to down-
regulation of TCR-β expression, suppression of T-cell blastogenesis, blockade of cytokine 
production, and, ultimately, inhibition of T-cell proliferation (Kullas et al., 2012). In agree-
ment with this, the cytolytic capacities of CD8+ T cells have been shown to be initiated by 
TCR interactions (Lewinsohn et al., 2011).
The phagosomal lifestyle of S. Typhimurium seems to be responsible for delayed MHC-I 
dependent antigen presentation and delayed expansion and contraction of the CD8+ T-cell 
response. Interestingly, even memory CD8+ T cells failed to undergo rapid expansion in 
response to infection with S. Typhimurium expressing the model antigen OVA (Luu et al., 
2006).
Additionally, Salmonella is able to induce apoptosis of Ag-specific CD4 T cells (Srini-
vasan et al., 2009). This is driven by SPI-2 virulence genes. In vivo studies by Ertelt et al. 
suggested that Salmonella undergoes, in a SPI-2 dependent manner, a selective culling of 
activated CD4+ T-cell subsets, which re-shapes the repertoire of antigen-specific T cells that 
persist later after infection (Ertelt et al., 2011).
Non-cognate activation of T cells
In addition to conventional activation by cognate peptide–MHC complexes presented 
by DCs, T cells can be indirectly stimulated (bystander stimulation) by Salmonella. This 
alternative pathway involves the well-characterized TLRs and NLRs, as well as other less 
known PRRs. It results in production of inflammatory cytokines that prime T cells at the 
site of infection (Broz and Monack, 2013b). Indeed, Salmonella has been proposed as a par-
ticularly appropriate model pathogen for study of non-cognate CD4 T-cell responses based 
on (i) strength of the Th1 response during infection, (ii) the requirement for CD4 T cells 
in bacterial clearance and (iii) the well-characterized inflammatory response to conserved 
molecular patterns induced by Salmonella infection (O’Donnell and McSorley, 2014).
B lymphocytes’ role
B lymphocytes have critical roles as positive and negative regulators of immunity. For 
instance, B cells have important contributions in acquired immunity against Salmonella 
infections, being essential for immunity during secondary challenge (McSorley and Jenkins, 
2000). Several studies describe antibody dependent (Mastroeni et al., 1993; McSorley and 
Jenkins, 2000; Mittrücker et al., 2000) and antibody independent Salmonella specific B cells 
responses (Barr et al., 2010; Mastroeni et al., 2000; Ugrinovic et al., 2003). These studies 
suggest that B cells can work as APCs and have a key role in the production of inflamma-
tory cytokines during Salmonella infection. The immunosuppressive role of B lymphocytes, 
classically associated with B cell-derived IL-10, is related to the regulation of autoimmune 
disease. This IL-10 also increase susceptibility to pathogens (Fillatreau, 2011; Fillatreau et 
al., 2008). In a recent study, Shen et al. described interleukin 35 (IL-35)-producing B cells 
as novel key players in the negative regulation of immunity (Shen et al., 2014). The authors 
showed that mice whose B cells did not express IL-35, displayed improved resistance to 
S. Typhimurium infection. The increased immunity found in these mice was associated to 
higher activation of macrophages and T cells, as well as an increased stimulatory function 
of B cells as APCs. The data presented in this work demonstrate that B cells can inhibit anti-
microbial immunity through production of IL-35 (Shen et al., 2014).
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One of the strategies developed by Salmonella to evade the action of B cells is to delay 
the formation of the germinal centre, which is necessary to produce high-affinity antibod-
ies against a specific pathogen (Cunningham et al., 2007). It has been shown that during 
Salmonella infection germinal centre formation and affinity maturation are delayed until the 
second month of infection. This differs greatly with conventional 7 day functional germinal 
centre formation. Furthermore, high-affinity antibodies start to be produced during the 
second week after immunization.
Persistence
One important aspect of typhoid Salmonella is its capacity to establish chronic infections. 
After adequate treatment the majority of patients who present acute typhoid fever recover; 
however, a significant percentage of patients (1–6%) develop a chronic infection (Levine et 
al., 1982; Monack et al., 2004a). These patients become asymptomatic chronic carriers and 
sporadically shed bacteria in their stool, allowing the pathogen to close its life cycle and to 
be transmitted to new hosts (Monack et al., 2004b). Despite the importance of Salmonella 
chronic infections, relatively little is known about the host immune response or virulence 
mechanisms that characterize long-term systemic infections. Since the majority of chroni-
cally infected patients are asymptomatic, the identification of potential targets is challenging 
(Shpargel et al., 1985; Sinnott and Teall, 1987). However, it is interesting to note that gut 
persistent infections are Salmonella pathogenicity island 1 (SPI-1) and Salmonella patho-
genicity island 2 (SPI-2) dependent (Lam et al., 2014). One study suggested that the human 
carrier state may be associated to an ineffective immune response (Thompson et al., 2009).
In this section we describe some recent advances with respect to S. Typhi and S. Typh-
imurium persistent host colonization.
Biofilm formation
Biofilm development is an important component of bacterial survival and a common 
source of persistent infections (Costerton et al., 1999). Salmonella are able to form biofilm 
in both biotic and abiotic surfaces. Moreover, there is a clear correlation between chronic 
infection and bacterial biofilm formation on the surface of gallstones (Gonzalez-Escobedo 
et al., 2011; Prouty et al., 2002). Epidemiological studies have revealed a strong associa-
tion between chronic carriers of S. Typhi and gallstones (Schiøler et al., 1983). Although, 
90% of chronically affected individuals have gallstones (Karaki and Matsubara, 1984) or 
other biliary track pathologies, this is not required to develop a carrier state (Monack et al., 
2004b). Salmonella biofilms have been found on gallstones in both S. Typhi patients and a 
mouse model of chronic S. Typhimurium infection (Crawford et al., 2010), suggesting both 
serovars share this biofilm strategy to survive in their host. Interestingly, bile has been shown 
to enhance S. Typhi biofilm formation (Gonzalez-Escobedo et al., 2011). Consistently, 
S. Typhi exhibits specific binding to cholesterol-coated surfaces, like gallstones (Crawford 
et al., 2008). FliC and OmpC are two proteins that were described to have a key role on 
initial adhesion to cholesterol-coated surfaces (Crawford et al., 2010). A hallmark of biofilm 
formation is the self-production of an extracellular matrix that ensures the integrity of the 
biofilm. The biofilm matrix is composed of EPS (extracellular polymeric substances) and 
water. Some components of biofilm EPS like cellulose, colonic acid and O antigen capsule 
are crucial for S. Typhi persistence and biofilm development (Crawford et al., 2008; Prouty 
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and Gunn, 2003; Prouty et al., 2002). Some studies show that bile present in the gallbladder 
induces the production of O-antigen, which facilitates S. Typhi biofilm formation on human 
gallstones (Crawford et al., 2008; Hall-Stoodley and Stoodley, 2009).
Persistence in immune cells
The study of the molecular mechanisms underlying persistent infections is limited by the 
lack of appropriate animal models that resist challenges using virulent strains of Salmonella. 
A suitable mice model was established in 2004 to study S. Typhimurium persistent infec-
tions (Monack et al., 2004b). In this model virulent S. Typhimurium strains cause long-term 
chronic infections. The persistent bacteria can then be monitored within macrophages in 
the MSNs up to 1 year post inoculation (Monack et al., 2004b). In addition to that, in vitro 
assays showed that hemophagocytic macrophages might represent a survival niche for Sal-
monella (Nix et al., 2007). Another study showed that persistent bacteria are sequestered 
within macrophages in systemic tissues, where they do not replicate and seem to be in a 
dormant-like state. This supports the idea of macrophages as a reservoir for persistent bac-
teria (Helaine et al., 2010). Another study published recently, showed that S. Typhimurium 
preferentially associates with anti-inflammatory/M2 macrophages at later stages of infec-
tion in mice (Eisele et al., 2013). This subset of macrophages does not express many of the 
defence mechanisms needed to eliminate invading microbes. Moreover, there are pathogens 
that have developed strategies to induce polarization of cells towards the M2 phenotype as 
a virulence mechanism ( Jensen et al., 2011).
In addition to macrophages, it has been shown that Salmonella remains for a long period 
of time within plasma cells, bone marrow B cell precursors, and all B cell subsets from the 
spleen (Castro-Eguiluz et al., 2009; López-Medina et al., 2015a). The ability of Salmonella 
to persist within B cells suggests that it developed a CD8+ T-cell response evasion mecha-
nism. In fact, Salmonella infection results in the enhanced expression of PD-L1 in B cells 
(López-Medina et al., 2015a). PD-L1 is a member of the programmed death-1 (PD-1)/
programmed death-ligands (PD-Ls) pathway that can turn off or reduce TCR signalling by 
recruiting phosphatases like SHP-1 and SHP-2 (Chemnitz et al., 2004; Freeman et al., 2000; 
Sheppard et al., 2004). The activation of the PD-1 : PD-Ls axis leads to impairment of CD8 
T cells during Salmonella infection (López-Medina et al., 2015b).
T3SS effectors and persistence
In order to shed light on the molecular mechanisms involved in persistence, Monack’s 
group performed a genome-wide screen to identify Salmonella genes required for persistent 
infection of the mice (Lawley et al., 2006). The screen revealed that SPI1 was necessary to 
maintain a persistent infection for at least 1 month post challenge. The authors confirmed 
that SPI1 effectors SipB, SipC, and SipD, which have a role on invasion or translocation 
of other effectors, contribute to establish a persistent infection. Similarly, another study 
showed that SPI1 is required for persistently infected mice to transmit S. Typhimurium 
to naive cage-mates (Lawley et al., 2008). Data from the genome screen mentioned above 
also showed that the SPI2 effector SseI was required for maintaining a long-term systemic 
infection. A follow-up study showed that SseI modulates macrophages and DCs by directly 
binding to IQGAP1, an important regulator of host cell migration (McLaughlin et al., 
2009). So, SseI blocks somehow the migration of macrophages and DCs interfering with 
the host immune system to clear systemic bacteria.
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Other elements that have been shown to contribute to persistent Salmonella infection 
are those that protect against host-derived antimicrobial peptides. Examples of these fac-
tors are PgtE, a modifier of the bacterial outer surface membrane (Lawley et al., 2006), and 
Mig-14, which provides resistance against anti-microbial peptides like VirK, RcsC, and YdeI 
(Erickson and Detweiler, 2006), both of them regulated by the PhoP/PhoQ system (Bader 
et al., 2005).
Persistence and metabolism
Recently, a pioneering study described how bacteria modulate the host cell metabolism to 
create an appropriate environment for long-term infection (Eisele et al., 2013). Firstly, the 
authors observed that PPARδ, which is a transcriptional factor involved in fatty acid metabo-
lism, is up-regulated in Salmonella infected M2 macrophages. This situation produces a shift 
in the metabolic state of the cell that leads to an increase in the level of glucose available to 
bacteria. Moreover, the authors show that pharmacological activation of PPARδ increases 
glucose availability and enhances bacterial replication in macrophages, while Salmonella 
fails to persist in macrophage lines lacking PPARδ. All together, these data, support the idea 
that Salmonella has evolved to survive long periods of time in M2 macrophages by harness-
ing the unique metabolism of these cells (Eisele et al., 2013).
Another relevant topic concerns genetic adaptation of bacteria during a persistent infec-
tion. A recent study describes the acquisition of adaptive mutations that facilitate persistence 
and survival in the host over the course of an infection (Søndberg and Jelsbak, 2016). In 
this work, the authors used a model of mice infected chronically with S. Typhimurium. 
They observed that bacteria acquire distinct single nucleotide polymorphisms (SNPs) in 
known regulators of metabolic and virulence genes. One such difference, the kdgR-SNP was 
confirmed to confer selective advantage during chronic infections and constitutes a true 
patho-adaptive mutation. Thus, the results provide evidence for rapid genetic adaptation 
to the host of S. Typhimurium during persistent infection (Søndberg and Jelsbak, 2016).
A non-mutational way for Salmonella to cause persistent infections even after antibiotic 
exposure is through the production of persister cells. These are rare cells, produced by all 
bacterial populations, that transiently become multidrug tolerant. It is thought this could be 
due to a state of low metabolic activity that leads to dormant or slow-growing cells (Bigger, 
1944; Helaine and Kugelberg, 2014; Maisonneuve and Gerdes, 2014). Salmonella persisters 
are part of a non-replicating population formed immediately after uptake by macrophages 
and are induced by vacuolar acidification and nutritional deprivation (Helaine et al., 2014). 
Furthermore, the majority of the 14 toxin–antitoxin (TA) modules contributed to intracel-
lular persister formation. A more comprehensive analysis of S. Typhimurium TA modules 
identified multiple toxins with anti-proliferative activity A selected group of the corre-
sponding TA modules were important for survival of intracellular bacteria inside fibroblasts 
(Lobato-Márquez et al., 2015). One of these toxins, TacT, is an acetyltransferase that blocks 
the primary amine group of amino acids on charged tRNA molecules, thereby inhibiting 
translation and promoting persister formation (Cheverton et al., 2016).
Transmission
During systemic salmonellosis, the life cycle completed when the pathogenic bacteria leave 
the former host to infect a naive one. This highlights the main issue with persistent infections: 
the constant shedding of virulent bacteria on faeces allows for propagation and maintenance 
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within a population. In a chronic infection scenario, Salmonella can persist in MLNs, bone 
marrow, and gallbladder, and periodically discharge Salmonella from the gallbladder to the 
small intestine in bile. The molecular mechanisms that control transmission of bacteria from 
host reservoirs are poorly understood. However, an interesting study proposed that host 
transmission of S. Typhimurium is controlled by virulence factors and indigenous intestinal 
microbiota. The authors described a model in which persistently infected mice provide a 
natural mode of S. Typhimurium transmission. In this context, a subgroup of mice (30%), 
called ‘supershedders’ was found to shed high levels of S. Typhimurium in their stools, lead-
ing to rapid transmission of the infection to naive hosts (Lawley et al., 2008). The authors 
showed that the development of the supershedder phenotype depends on SPI1 and SPI2. 
Moreover, treatment with antibiotics induced the supershedder state in mice, suggesting 
that the indigenous intestinal microbiota has a role in controlling this phenotype.
Concluding remarks
We have described recent advances concerning the strategies used by Salmonella to evade 
both innate and adaptive immune responses. Most of these evasion mechanisms are directly 
related to T3SS1 and 2 and to the different effectors injected by them (Table 6.1). In the last 
two decades more than 40 effectors have been identified, and the biochemical activity and 
host targets for some of them have been successfully characterized. However, the precise 
role of many of them and their contribution to the relationship between Salmonella and 
its hosts at the cellular and systemic level remain unknown. A better understanding of the 
specific functions of these effector proteins will allow us to unravel the complex network of 
action of these molecules and to decipher the underlying mechanisms that enable Salmo-
nella to evade the host immune system.
For instance, we have to define the role of T3SS effectors in establishing different intra-
cellular lifestyles and decipher which signals enable Salmonella to survive intracellularly 
versus proliferate and escape, depending on the cellular type.
Another challenge is to improve our understanding of Salmonella control of the fusion of 
SCV to the lysosome. The identification of new and appropriate SCV markers and the devel-
opment of new imaging technologies will improve the detection of intracellular Salmonella 
and ultimately help us to answer these questions.
One of the most significant challenges concerns host specificity achieved by different 
Salmonella serovars. There is an obvious shortage of appropriate models. For example, there 
is no suitable animal model for the typhoid human pathogen S. Typhi. Therefore, in vivo 
studies for this serovar are deficient. Researchers tend to use the S. Typhimurium-infected 
mouse model to study systemic typhoid-like disease. However, extrapolation of results 
obtained in S. Typhimurium to S. Typhi is not always possible. The development of new 
animal and cellular models are slowly helping us surmount this lack of appropriate tools. 
One example is the recent work of Fresnay et al., who established a controlled human infec-
tion model with wt S. Typhi using cutting-edge multichromatic flow cytometry to analyse 
the pre-challenge immunological status and its correlation with the subsequent clinical out-
come (Fresnay et al., 2016). Specifically, the authors investigated the relationship between S. 
Typhi-specific CD8+ T-cell responses before exposure to wt S. Typhi and clinical outcome, 
i.e. whether the participants who were challenged developed disease or not. They observed 
higher baseline levels of multi functional S. Typhi-specific CD8+ T in patients who did not 
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Table 6.1 Role of T3SS effectors in Salmonella evasion of the immune system
Effector T3SS Interaction with the immune system References
AvrA 1 Inhibits NF-κB and JNK pro-inflammatory 
pathways
Collier-Hyams et al. (2002), 
Jones et al. (2008b)
CigR 2 Involved in biofilm formation Yin et al. (2016)
GogA Inhibits inflammation by targeting NF-κB 
signalling
Sun et al. (2016)
GogB 2 Limits inflammation preventing NF-κB Pilar et al. (2012)
GtgA 2 Inhibits inflammation by targeting NF-κB 
signalling
Sun et al. (2016)
GtgE 1/2 Counters a Rab32-dependent host defence 
pathway
Spanò et al. (2016)
PipA Inhibits inflammation by targeting NF-κB 
signalling
Sun et al. (2016)
PipB 2 Role in iNOS production in chicken oviduct 
epithelial cells
Li et al. (2009)
PrgJ ? Activates caspase-1 through NLRC4 Miao et al. (2010) 
PipB2 1/2 Inhibits dendritic cell migration McLaughlin et al. (2014)
SifA 2 Inhibits dendritic cell migration McLaughlin et al. (2014)
SipA/
SspA
1 Elicits accumulation of PERP to the apical 
surface of colonic epithelial cells that leads to 
inflammatory responses
Hallstrom et al. (2015)
SipB 1 Contributes to activation and release of IL-18 Dreher et al. (2002)
SipC/
SspC
1 Elicits accumulation of PERP to the apical 
surface of colonic epithelial cells that leads to 
inflammatory responses
Hallstrom and McCormick 
(2016)
SipD 1 Triggers cell death in macrophages Arizmendi et al. (2016)
SlrP 1/2 Inhibits dendritic cell migration McLaughlin et al. (2014)
SopA 1 Stimulates inflammation targeting TRIM56 and 
TRIM65
Kamanova et al. (2016)
SopB 1 Inhibits production of mitochondrial superoxide 
ROS
Activates MAPK and NF-κB signalling through 
stimulation of Rho-family GTPases
Bruno et al. (2009),  
Ruan et al. (2016)
SopD 1/2? Contributes to PMN migration and fluid secretion 
in bovine intestine
Zhang et al. (2002)
SopD2 2 Counters a Rab32-dependent host defence 
pathway
Spanò et al. (2016)
SopE 1 Induces caspase-1 dependent pro-inflammatory 
responses. Activates MAPK and NF-κB 
signalling through stimulation of Rho-family 
GTPases
Bruno et al. (2009), 
Hoffmann et al. (2010), 
Müller et al. (2009)
SopE2 1 Activates MAPK and NF-κB signalling through 
stimulation of Rho-family GTPases
Bruno et al. (2009)
SpiC/
SsaB
2 Inhibits dendritic cell migration McLaughlin et al. (2014)
SptP 1 Inhibits p38 MAPK signalling. Suppresses 
degranulation of local mast cells
Choi et al. (2013),  
Tenor et al. (2004)
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develop the disease. Their observations also indicate that S. Typhi-specific CD8+ T migrated 
not only to mucosal sites, but also to secondary lymphoid tissues. These localized events, 
delay disease onset. They also suggested that co-production of MIP-1β with other cytokines 
is a key component in protection against S. Typhi (Fresnay et al., 2016). This type of studies 
is key to identify an early selection of novel vaccine candidates for further evaluation in clini-
cal trials. These models are also necessary to understand the role of certain T3SS effectors 
that may only be relevant in certain cell types or animal species.
Advances in techniques for single cell analysis allow us to study bacterial subpopulations 
that have different expression profiles of effectors and other virulence factors.
Finally, a more precise understanding of the interactions between Salmonella and the 
host immune system could help us design new approaches to modify the progression of 
Salmonella infections, strengthening key components of the immune response.
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Effector T3SS Interaction with the immune system References
SpvB 2 Contributes to gut inflammation through a 
T3SS2-dependent pathway
Käppeli et al. (2011)
SpvC 1/2 Anti-inflammatory in mice. Interferes with 
immunity in plants
Haneda et al. (2012); 
Neumann et al. (2014)
SpvD 1/2 Inhibits nuclear transport of NF-κB p65 Rolhion et al. (2016)
SseF 2 Inhibits dendritic cell migration McLaughlin et al. (2014)
SseI/
SrfH
2 Modulates cell migration of macrophages and 
dendritic cells
McLaughlin et al. (2009), 
Worley et al. (2006)
SseK1 1/2 Interferes with NF-κB activation Li et al. (2013)
SseK3 2 Interferes with NF-κB activation Yang et al. (2015)
SseL 2 Inhibits autophagy Mesquita et al. (2012)
SspH1 1/2 Inhibits NF-κB-dependent gene expression Haraga and Miller (2003), 
Haraga et al. (2006)
SspH2 2 Enhance SG1-dependent NLR-mediated 
immunity
Bhavsar et al. (2013), 
McLaughlin et al. (2014)
Inhibits dendritic cell migration
SteA 1/2 Represses genes involved in immune responses Cardenal-Muñoz et al. 
(2014)
SteB Biofilm formation Dong et al. (2008),  
McGhie et al. (2009)
Table 6.1 Continued
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